Thyrocare Technologies Limited IPO
Thyrocare Technologies Limited was a mainboard IPO in the Healthcare Service Provider sector, offered at ₹140–₹148.67 per share to raise ₹479 crore. The issue was subscribed 73.55× overall (QIBs 73.18×, NIIs 225.3×, retail 8.73×). It listed on 9 May 2016 at ₹222 and closed its first day at ₹206, a listing gain of +38.7% versus the ₹148.67 issue price. It now trades around ₹456 (+206.9% versus the issue price).
Frequently asked questions
- How many times was the Thyrocare Technologies Limited IPO subscribed?
- The Thyrocare Technologies Limited IPO was subscribed 73.55× overall — 73.18× in the QIB category, 225.3× among non-institutional investors, 8.73× in retail.
- What were the Thyrocare Technologies Limited IPO listing gains?
- Thyrocare Technologies Limited listed on 9 May 2016 at ₹222, closing its first day at ₹206 — a listing gain of +38.7% versus the ₹148.67 issue price.
- What were the retail allotment odds for the Thyrocare Technologies Limited IPO?
- Retail was subscribed 8.73×, so a single-lot application had roughly a 11.5% chance of allotment (about 1 in 9), and allotment was finalised on 3 May 2016.
- What was the price band and lot size of the Thyrocare Technologies Limited IPO?
- The price band was ₹140–₹148.67 per share, with a minimum lot of 33 shares (₹4,906 at the upper band).
- Who were the registrar and lead manager for the Thyrocare Technologies Limited IPO?
- Link Intime India Private Limited was the registrar to the issue.